ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Universal Logistics Holdings, Inc. engages in the provision of customized transportation and logistics solutions. It operates through the following segments: Contract Logistics, Intermodal, Trucking, Company-Managed Brokerage, and Other. The Contract Logistics segment delivers value-added and/or dedicated transportation services to support inbound logistics to original equipment manufacturers and major retailers on a contractual basis, generally pursuant to terms of one year or longer. The Intermodal segment caters local and regional drayage moves coordinated by company-managed terminals using a mix of owner-operators, company equipment and third-party capacity providers. The Trucking segment includes individual freight shipments coordinated by its agents and company-managed terminals using a mix of owner-operators, company equipment, and broker carriers. The Company-Managed Brokerage segment covers pick-up and delivery of individual freight shipments using broker carriers, coordinated by its company-managed operations. The Other segment focuses on support services to other subsidiaries. The company was founded in 1932 and is headquartered in Warren, MI.

NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company is headquartered in Bangkok, Thailand.

Katapult Holdings, Inc. is an e-commerce focused financial technology company, which engages in the provision of e-commerce point-of-sale ("POS") lease-purchase options for nonprime U.S. consumers. It offers its customers a lease purchase transaction processing system with no long-term obligation and options for ownership. The company was founded in August 2019 and is headquartered in Plano, TX.

NuZee, Inc. is a coffee and technologies company, which engages in the manufacture, market, distribution, commercialization, and development of functional beverages products. Its products include single serve pour over, Dripkit pour over, coffee brew bag, private label, and licensing under the Stone Brewing Coffee and Dripkit brands. It operates through the North America and South Korea geographical segments. The company was founded on November 9, 2011 and is headquartered in Richardson, TX.

Mobix Labs, Inc. operates as a semiconductor company. It develops wireless and connected solutions that are designed to cater to a broad range of applications in markets including 5G infrastructure, satellite communications, automotive, consumer electronics, e-mobility, healthcare, infrastructure and defense. The company is headquartered in Irvine, CA.

Infobird Co. Ltd. engages in the provision of standard and customized customer relationship management cloud-based services. It offers software-as-a-service (SaaS) and business process outsourcing (BPO) services to clients, through its variable interest entity. The company was founded in 2001 and is headquartered in Beijing, China.

Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs which aim to treat neurodegenerative diseases such as Alzheimer's (AD) and Parkinson's (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Its product pipeline also includes ANVS405 and ANVS301, which focus on the treatment of traumatic brain injury, stroke, and advanced AD. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Malvern, PA.

Cullinan Therapeutics, Inc. is a biopharmaceutical company engaged in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.